These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9197912

  • 1. Paroxetine efficacy in the treatment of generalized anxiety disorder.
    Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L.
    Acta Psychiatr Scand; 1997 May; 95(5):444-50. PubMed ID: 9197912
    [Abstract] [Full Text] [Related]

  • 2. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I, Colombo G, Furlanut M, Benetello P.
    Int J Clin Pharmacol Res; 1989 May; 9(3):203-8. PubMed ID: 2568350
    [Abstract] [Full Text] [Related]

  • 3. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR.
    J Clin Psychiatry; 2001 May; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N, Boulenger JP.
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [Abstract] [Full Text] [Related]

  • 5. Pharmacotherapy of generalized anxiety disorder.
    Rickels K, Rynn M.
    J Clin Psychiatry; 2002 Sep; 63 Suppl 14():9-16. PubMed ID: 12562113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G, Beeské S, Stahl SM.
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [Abstract] [Full Text] [Related]

  • 9. Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting.
    Gibiino S, Mori E, De Ronchi D, Serretti A.
    J Clin Psychopharmacol; 2013 Aug; 33(4):565-9. PubMed ID: 23764690
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
    Rickels K, Downing R, Schweizer E, Hassman H.
    Arch Gen Psychiatry; 1993 Nov; 50(11):884-95. PubMed ID: 8215814
    [Abstract] [Full Text] [Related]

  • 13. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [Abstract] [Full Text] [Related]

  • 14. Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients.
    Montanari G, Schiaulini P, Covre A, Steffan A, Furlanut M.
    Pharmacol Res; 1992 Dec; 25 Suppl 1():83-4. PubMed ID: 1354861
    [No Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.
    Feltner DE, Harness J, Brock J, Sambunaris A, Cappelleri JC, Morlock R.
    CNS Neurosci Ther; 2009 Dec; 15(1):12-8. PubMed ID: 19228175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V, Maffei F, Montanaro N, Morandini G.
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.